Prior studies have highlighted the overexpression of RARγ in human CRC tissues and multiple CRC cell lines, findings that suggest an increase in sensitivity to chemotherapeutic agents and a potential counteraction of multidrug resistance mechanisms.24 This evidence concerns the gene RARG and colorectal carcinoma.